Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Clene ( (CLNN) ) has issued an announcement.
On May 18, 2026, Clene Inc. amended its August 13, 2025 senior secured convertible promissory notes with AE Capital Limited, A Global Chorus Foundation and Glenn and Shelina Way, extending the maturity to the earlier of August 13, 2027 or a change in control and deferring planned $150,000 monthly principal and interest payments so that the full balance is due at maturity. The changes ease near‑term cash obligations while preserving other note terms, potentially improving liquidity management and financial flexibility for the company and its creditors.
On May 21, 2026, stockholders approved an amendment to Clene’s Amended 2020 Stock Plan, increasing the shares of common stock reserved for issuance by 1,000,000, and also ratified Deloitte & Touche LLP as auditor, re‑elected three Class III directors and backed advisory compensation for named executive officers. These annual meeting decisions support Clene’s ability to use equity incentives for retention and growth, maintain audit continuity and reinforce existing leadership and pay structures, shaping governance and capital strategy going forward.
The most recent analyst rating on (CLNN) stock is a Buy with a $50.00 price target. To see the full list of analyst forecasts on Clene stock, see the CLNN Stock Forecast page.
Spark’s Take on CLNN Stock
According to Spark, TipRanks’ AI Analyst, CLNN is a Neutral.
The score is held down primarily by very weak financial performance (minimal revenue, large ongoing losses, heavy cash burn, and negative equity). Offsetting factors include improving technical trend/momentum and positive corporate catalysts (FDA pathway update and runway-extending financings), but valuation remains challenged given persistent losses and no dividend yield support.
To see Spark’s full report on CLNN stock, click here.
More about Clene
Clene Inc., a publicly traded company, has issued senior secured convertible promissory notes and maintains an equity compensation program under its Amended 2020 Stock Plan. The company engages with institutional investors and individual stockholders through annual meetings to approve director elections, executive compensation, auditor appointments and equity plan changes.
Average Trading Volume: 487,107
Technical Sentiment Signal: Buy
Current Market Cap: $88.17M
See more data about CLNN stock on TipRanks’ Stock Analysis page.